United States Rep. Timothy Waltz (D-MN), along with over 30 bipartisan co-sponsors, has introduced legislation, HR 5520: The VA Medicinal Cannabis Research Act of 2018, to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans.
Cannabis exposure in adolescents and young adults is not associated with any significant long-term detrimental effects on cognitive performance, according to a systematic literature review published today in the journal JAMA Psychiatry.
The Department of Health had up to one year to act on the recommendations of the Board. In a move that excited patients and advocates, Dr. Rachel Levine on behalf of the Department acted quickly adopting all of the recommendations above.
Republican Senator Cory Gardner (CO) says that he has received a verbal commitment from President Donald Trump specifying that the administration will not take action to disrupt marijuana markets in states that legally regulate the substance. In response to the administration's pledge, NORML Director Erik Altieri stated: "[I]t is time for Congress to do its part and swiftly move forward bipartisan legislation that explicitly provides states with the authority and autonomy to set their own marijuana policies absent the fear of federal incursion."